One key contributor to this dysfunction is the elevated level of plasminogen activator inhibitor-1 (PAI-1) found in individuals with obesity, which suppresses fibrin clot degradation and thereby promotes thrombosis [118]. This evidence concerns the gene SERPINE1 and obesity due to melanocortin 4 receptor deficiency.